Compare NLOP & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NLOP | INGN |
|---|---|---|
| Founded | N/A | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.4M | 175.6M |
| IPO Year | 2022 | 2013 |
| Metric | NLOP | INGN |
|---|---|---|
| Price | $14.65 | $6.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | 188.3K | ★ 249.2K |
| Earning Date | 02-25-2026 | 05-06-2026 |
| Dividend Yield | ★ 45.58% | N/A |
| EPS Growth | N/A | ★ 43.42 |
| EPS | N/A | ★ N/A |
| Revenue | $118,915,000.00 | ★ $348,668,000.00 |
| Revenue This Year | N/A | $7.92 |
| Revenue Next Year | N/A | $7.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.86 |
| 52 Week Low | $12.76 | $5.34 |
| 52 Week High | $34.53 | $9.13 |
| Indicator | NLOP | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 45.63 | 49.72 |
| Support Level | $13.71 | $5.95 |
| Resistance Level | $14.70 | $6.83 |
| Average True Range (ATR) | 0.38 | 0.23 |
| MACD | 0.30 | 0.02 |
| Stochastic Oscillator | 62.16 | 31.06 |
Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns a diversified portfolio of office properties that are primarily leased to corporate tenants on a single-tenant, net-lease basis. Its net leases generally specify a base rent with rent increases and require the tenant to pay substantially all costs associated with operating and maintaining the property. Its portfolio includes approximately 1.2 million square feet of Green-Certified Buildings, 2 LEED-certified buildings, and 1 BREEAM-certified building.
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.